UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting of Plasmodium falciparum Liver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates

Infection and Immunity, 2008-01, Vol.76 (1), p.229-238

2008

Volltextzugriff (PDF)

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults

Vaccine, 2024-04, Vol.42 (12), p.3066-3074

2024

Volltextzugriff (PDF)

Randomized Trial of 3-Dose Regimens of Tafenoquine (WR238605) versus Low-Dose Primaquine for Preventing Plasmodium vivax Malaria Relapse

Clinical infectious diseases, 2004-10, Vol.39 (8), p.1095-1103

2004

Volltextzugriff (PDF)

Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of Plasmodium vivax Malaria in Thailand

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1282-1287

1999

Volltextzugriff (PDF)

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

The Journal of infectious diseases, 1995-06, Vol.171 (6), p.1576-1585

1995

Volltextzugriff (PDF)

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

Tropical medicine & international health, 2007-01, Vol.12 (1), p.37-46

2007

Volltextzugriff (PDF)

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000-09, Vol.94 (5), p.537-544

2000

Volltextzugriff (PDF)

CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1 19) formulated in oil-based Montanides

Vaccine, 2003-06, Vol.21 (21), p.2923-2932

2003

Volltextzugriff (PDF)

Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway

The Journal of immunology (1950), 2004-04, Vol.172 (8), p.4926-4933

2004

Volltextzugriff (PDF)

Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes

The Journal of infectious diseases, 1996-08, Vol.174 (2), p.361-366

1996

Volltextzugriff (PDF)

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

The Lancet infectious diseases, 2017-08, Vol.17 (8), p.854-866

2017

Volltextzugriff (PDF)

In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand

Bulletin of the World Health Organization, 1999-01, Vol.77 (5), p.392-398

1999

Volltextzugriff (PDF)

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys

Vaccine, 2009-12, Vol.28 (2), p.452-462

2009

Volltextzugriff (PDF)

Comparison of a rapid field immunochromatographic test to expert microscopy for the detection of Plasmodium falciparum asexual parasitemia in Thailand

Acta tropica, 1999-10, Vol.73 (3), p.263-273

1999

Volltextzugriff (PDF)

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans

The Journal of infectious diseases, 1994-04, Vol.169 (4), p.927-931

1994

Volltextzugriff (PDF)

Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria

The Journal of infectious diseases, 2001-02, Vol.183 (4), p.640-647

2001

Volltextzugriff (PDF)

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against Plasmodium falciparum Malaria

The New England journal of medicine, 1997-01, Vol.336 (2), p.86-91

1997

Volltextzugriff (PDF)

Pharmacokinetics of Mefloquine Combined with Artesunate in Children with Acute Falciparum Malaria

Antimicrobial Agents and Chemotherapy, 1999-02, Vol.43 (2), p.341-346

1999

Volltextzugriff (PDF)

Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria

The American journal of tropical medicine and hygiene, 1998-01, Vol.58 (1), p.11-16

1998

Volltextzugriff (PDF)

Purification, Characterization, and Immunogenicity of the Refolded Ectodomain of the Plasmodium falciparum Apical Membrane Antigen 1 Expressed in Escherichia coli

Infection and Immunity, 2002-06, Vol.70 (6), p.3101-3110

2002

Volltextzugriff (PDF)

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

The Lancet (British edition), 1992-09, Vol.340 (8821), p.689-694

1992

Volltextzugriff (PDF)

Human ehrlichiosis in Thailand

The Lancet (British edition), 1997-09, Vol.350 (9080), p.785-786

1997

Volltextzugriff (PDF)

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum

The Lancet (British edition), 1994-06, Vol.343 (8910), p.1396-1397

1994

Volltextzugriff (PDF)

Regulation of leukocyte adhesion molecules CD11b/CD18 and leukocyte adhesion molecule-1 on phagocytic cells activated by malaria pigment

The American journal of tropical medicine and hygiene, 1997-10, Vol.57 (4), p.383-388

1997

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting of Plasmodium falciparum Liver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults

Randomized Trial of 3-Dose Regimens of Tafenoquine (WR238605) versus Low-Dose Primaquine for Preventing Plasmodium vivax Malaria Relapse

Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of Plasmodium vivax Malaria in Thailand

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine

CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1 19) formulated in oil-based Montanides

Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway

Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys

Comparison of a rapid field immunochromatographic test to expert microscopy for the detection of Plasmodium falciparum asexual parasitemia in Thailand

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans

Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against Plasmodium falciparum Malaria

Pharmacokinetics of Mefloquine Combined with Artesunate in Children with Acute Falciparum Malaria

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A

Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria

Purification, Characterization, and Immunogenicity of the Refolded Ectodomain of the Plasmodium falciparum Apical Membrane Antigen 1 Expressed in Escherichia coli

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

Human ehrlichiosis in Thailand

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum

Regulation of leukocyte adhesion molecules CD11b/CD18 and leukocyte adhesion molecule-1 on phagocytic cells activated by malaria pigment

Suchergebnisse filtern